Search

Search Constraints

You searched for: Author/Creator Lorigan, Paul

Search Results

1. 25-hydroxyvitamin D serum levels in patients with high risk resected melanoma treated in an adjuvant bevacizumab trial. Issue 7 (2nd October 2018)

2. A randomized, open‐label clinical trial of tasisulam sodium versus paclitaxel as second‐line treatment in patients with metastatic melanoma. Issue 13 (26th March 2014)

3. A randomized, open‐label clinical trial of tasisulam sodium versus paclitaxel as second‐line treatment in patients with metastatic melanoma. Issue 13 (26th March 2014)

7. An open-label, multicentre safety study of vemurafenib in patients with BRAFV600-mutant metastatic melanoma: final analysis and a validated prognostic scoring system. (January 2019)

9. Avelumab expanded access program in metastatic Merkel cell carcinoma: Efficacy and safety findings from patients in Europe and the Middle East. Issue 11 (3rd August 2021)

10. Checkpoint inhibitor‐associated bullous cutaneous immune‐related adverse events: a multicentre observational study. (1st December 2022)